28 Days
Source:
زاد الاردن
New drug reduces relapse risk in autoimmune disease
An international study reported that the drug "Opexcilimab" significantly reduces the risk of relapse in IgG4-related disease, a rare and often severe autoimmune condition frequently misdiagnosed as cancer. The study showed that patients who received the medication had a relapse rate of up to 26.8%, compared to 54.6% in the placebo group. This represents a breakthrough in treatment options for affected individuals, with less reliance on steroids and better disease control.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)